The COQ8B antibody is a polyclonal or monoclonal immunoglobulin designed to bind specifically to the COQ8B protein. This protein is localized in mitochondrial matrices and is essential for CoQ10 production, a molecule required for oxidative phosphorylation, antioxidant defense, and mitochondrial function . The antibody is primarily used in laboratory settings for protein detection via immunoblotting, immunohistochemistry (IHC), or enzyme-linked immunosorbent assays (ELISA).
Mitochondrial localization: Studies using COQ8B antibodies confirmed its presence in mitochondrial matrices, where it interacts with COQ6 and COQ7 to facilitate CoQ10 biosynthesis .
Disease association: Mutations in COQ8B cause primary CoQ10 deficiency, linked to steroid-resistant nephrotic syndrome (SRNS), focal segmental glomerulosclerosis (FSGS), and mitochondrial dysfunction .
Kidney diseases: IHC using COQ8B antibodies revealed podocyte-specific protein loss in patients with SRNS and FSGS, aiding in differentiating genetic causes of nephropathy .
Therapeutic monitoring: ELISA-based quantification of COQ8B protein levels has been proposed to assess CoQ10 supplementation efficacy in clinical trials .
Yeast models: Antibodies were used to validate COQ8B gene complementation in ΔCOQ8 yeast strains, confirming its role in CoQ10 biosynthesis .
Cancer research: Inhibition of COQ8B via small molecules (e.g., UNC-CA157) reduced CoQ10 levels, potentially targeting cancer cells reliant on CoQ10 for survival .
KEGG: dre:799071
STRING: 7955.ENSDARP00000013965